Jill Brooks
About
Jill Brooks is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine.
According to data from OpenAlex, Jill Brooks has authored 43 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 17 papers in Immunology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Jill Brooks's work include Viral-associated cancers and disorders (19 papers), Immune Cell Function and Interaction (13 papers) and Lymphoma Diagnosis and Treatment (10 papers). Jill Brooks is often cited by papers focused on Viral-associated cancers and disorders (19 papers), Immune Cell Function and Interaction (13 papers) and Lymphoma Diagnosis and Treatment (10 papers). Jill Brooks collaborates with scholars based in United Kingdom, United States and Netherlands. Jill Brooks's co-authors include Alan B. Rickinson, Wendy A. Thomas, Graham S. Taylor, Heather M. Long, R J Murray, Michael G. Kurilla, Andrew D. Hislop, Martin Rowe, E Kieff and Rosemary J. Tierney and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.
In The Last Decade
Jill Brooks
41 papers receiving 2.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jill Brooks United Kingdom | 22 | 1.5k | 1.2k | 695 | 654 | 273 | 43 | 2.3k | ||
| Wendy A. Thomas United Kingdom | 17 | 1.5k 1.0× | 1.1k 0.9× | 645 0.9× | 677 1.0× | 192 0.7× | 18 | 1.9k | ||
| Claire Shannon‐Lowe United Kingdom | 27 | 1.7k 1.1× | 830 0.7× | 696 1.0× | 791 1.2× | 272 1.0× | 36 | 2.3k | ||
| Heather M. Long United Kingdom | 24 | 1.2k 0.8× | 902 0.8× | 596 0.9× | 553 0.8× | 270 1.0× | 37 | 1.8k | ||
| Neil Blake United Kingdom | 23 | 1.1k 0.7× | 1.0k 0.8× | 735 1.1× | 381 0.6× | 155 0.6× | 38 | 2.0k | ||
| Jerome E. Tanner Canada | 19 | 944 0.6× | 581 0.5× | 530 0.8× | 381 0.6× | 374 1.4× | 34 | 1.7k | ||
| Caroline Alfieri Canada | 21 | 1.5k 1.0× | 493 0.4× | 639 0.9× | 675 1.0× | 585 2.1× | 38 | 2.0k | ||
| Kate Cwynarski United Kingdom | 35 | 1.1k 0.7× | 825 0.7× | 464 0.7× | 1.3k 2.0× | 149 0.5× | 100 | 3.2k | ||
| Barbro Ehlin‐Henriksson Sweden | 25 | 1.1k 0.7× | 839 0.7× | 418 0.6× | 569 0.9× | 334 1.2× | 43 | 1.8k | ||
| Hisashi Gondo Japan | 29 | 792 0.5× | 1.1k 0.9× | 542 0.8× | 317 0.5× | 252 0.9× | 79 | 2.9k | ||
| T B Sculley Australia | 26 | 1.8k 1.2× | 937 0.8× | 776 1.1× | 878 1.3× | 564 2.1× | 53 | 2.3k |
Countries citing papers authored by Jill Brooks
Since
Specialization
Citations
This map shows the geographic impact of Jill Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Brooks more than expected).
Fields of papers citing papers by Jill Brooks
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jill Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Brooks. The network helps show where Jill Brooks may publish in the future.
Co-authorship network of co-authors of Jill Brooks
This figure shows the co-authorship network connecting the top 25 collaborators of Jill Brooks. A scholar is included among the top collaborators of Jill Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Brooks. Jill Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Shephard, Adam, Hanya Mahmood, Shan E Ahmed Raza, et al.. (2025). Development and validation of an artificial intelligence-based pipeline for predicting oral epithelial dysplasia malignant transformation. Communications Medicine. 5(1). 186–186.
2.
Payne, Karl, et al.. (2024). Exploring the impact of intra-tumoural heterogeneity on liquid biopsy cell-free DNA methylation and copy number in head and neck squamous cell carcinoma. Oral Oncology. 158. 107011–107011.
3.
Payne, Karl, Jill Brooks, Nikolaos Batis, et al.. (2024). Circulating tumour DNA detects somatic variants contributing to spatial and temporal intra-tumoural heterogeneity in head and neck squamous cell carcinoma. Frontiers in Oncology. 14. 1374816–1374816.
4.
Haigh, Tracey A., Alison M. Leese, Yolanda van Wijck, et al.. (2024). Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis. PLoS Pathogens. 20(6). e1012177–e1012177.
5.
Brooks, Jill, Yuanning Zheng, Benjamin E. Willcox, et al.. (2024). Digital Spatial Profiling identifies distinct patterns of immuno-oncology-related gene expression within oropharyngeal tumours in relation to HPV and p16 status. Frontiers in Oncology. 14. 1428741–1428741.
6.
Shephard, Adam, Raja Muhammad Saad Bashir, Hanya Mahmood, et al.. (2024). A fully automated and explainable algorithm for predicting malignant transformation in oral epithelial dysplasia. npj Precision Oncology. 8(1). 137–137.
7.
Mahmood, Hanya, Adam Shephard, Mike Bradburn, et al.. (2023). Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia. British Journal of Cancer. 129(10). 1599–1607.
8.
Mehanna, Hisham, Ben Carter, A. Hartley, et al.. (2023). Patient preference for commonly‐used, head and neck cancer‐specific quality of life questionnaires in the follow‐up setting (Determin): A multi‐centre randomised controlled trial and mixed methods study. Clinical Otolaryngology. 48(4). 613–622.
9.
Payne, Karl, Jill Brooks, Nikolaos Batis, et al.. (2022). Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma. Head & Neck. 44(11). 2545–2554.
10.
Whalley, Celina, Karl Payne, Enric Domingo, et al.. (2021). Ultra-Low DNA Input into Whole Genome Methylation Assays and Detection of Oncogenic Methylation and Copy Number Variants in Circulating Tumour DNA. Epigenomes. 5(1). 6–6.
11.
Mehanna, Hisham, Sara Tous, Jill Brooks, et al.. (2020). 911O Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study. Annals of Oncology. 31. S658–S659.
12.
Bryant, Jennifer, Nikolaos Batis, M. Gill Hartley, et al.. (2019). Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma. Oncotarget. 10(50). 5229–5244.
13.
Brooks, Jill, Steven P. Lee, Alison M. Leese, et al.. (2009). Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition. The Journal of Immunology. 182(4). 1919–1928.
14.
Lee, Steven P., Jill Brooks, Wendy A. Thomas, et al.. (2004). CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1. The Journal of Experimental Medicine. 199(10). 1409–1420.
15.
Crotzer, Victoria L., Jill Brooks, Jeffrey Shabanowitz, et al.. (2000). Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines. The Journal of Immunology. 164(12). 6120–6129.
16.
Campos‐Lima, Pedro O. de, Victor Levitsky, Jill Brooks, et al.. (1994). T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.. The Journal of Experimental Medicine. 179(4). 1297–1305.
17.
Pazmany, L, Sarah Rowland‐Jones, Stéphane Huet, et al.. (1992). Genetic modulation of antigen presentation by HLA-B27 molecules.. The Journal of Experimental Medicine. 175(2). 361–369.
18.
Murray, R J, Michael G. Kurilla, Jill Brooks, et al.. (1992). Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.. The Journal of Experimental Medicine. 176(1). 157–168.
19.
Masucci, Maria G., Riccardo Gavioli, R J Murray, et al.. (1992). Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. International Immunology. 4(11). 1283–1292.
20.
Murray, R J, Jill Brooks, Alan B. Rickinson, & Martin Rowe. (1990). Cross‐recognition of a mouse H‐2‐peptide complex by human HLA‐restricted cytotoxic T cells. European Journal of Immunology. 20(3). 659–664.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Wendy A. Thomas Breakdown of academic impact, for papers by Claire Shannon‐Lowe Breakdown of academic impact, for papers by Heather M. Long Breakdown of academic impact, for papers by Neil Blake Breakdown of academic impact, for papers by Jerome E. Tanner Breakdown of academic impact, for papers by Caroline Alfieri Breakdown of academic impact, for papers by Kate Cwynarski Breakdown of academic impact, for papers by Barbro Ehlin‐Henriksson Breakdown of academic impact, for papers by Hisashi Gondo Breakdown of academic impact, for papers by T B Sculley